Krsnaa Diagnostics Limited Total Liabilities

Latest as of September 2025: Rs5.84 Billion INR ≈ $63.13 Million USD

Krsnaa Diagnostics Limited total liabilities. Based on the latest financial reports, Krsnaa Diagnostics Limited (KRSNAA) has total liabilities worth Rs5.84 Billion INR (≈ $63.13 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check KRSNAA asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Krsnaa Diagnostics Limited (2017–2025)

Total liabilities of Krsnaa Diagnostics Limited from 2017 to 2025. This chart illustrates how Krsnaa Diagnostics Limited's total liabilities have evolved over time, based on quarterly financial data.

Krsnaa Diagnostics Limited Competitors by Total Liabilities

The table below lists competitors of Krsnaa Diagnostics Limited ranked by their total liabilities.

Company Country Total Liabilities
IG Petrochemicals Limited
NSE:IGPL
India Rs9.68 Billion
Chunil Express
KO:000650
Korea ₩42.56 Billion
Fiera Capital Corporation
TO:FSZ
Canada CA$956.48 Million
Quercus TFI SA
WAR:QRS
Poland zł143.83 Million
Aekyung Industrial Co Ltd
KO:018250
Korea ₩82.54 Billion
Shenzhen Weiye Decoration Group Co Ltd
SHE:300621
China CN¥13.51 Billion
Entrada Therapeutics Inc
NASDAQ:TRDA
USA $65.47 Million

Liability Composition Analysis (2017–2025)

This chart breaks down Krsnaa Diagnostics Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see KRSNAA total asset value.

Liquidity & Leverage Metrics

Krsnaa Diagnostics Limited Total Liabilities Ratios Explained

Krsnaa Diagnostics Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.42 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.63 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.39 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Krsnaa Diagnostics Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Krsnaa Diagnostics Limited (2017–2025)

The table below shows the annual total liabilities of Krsnaa Diagnostics Limited from 2017 to 2025.

Year Total Liabilities Change
2025-03-31 Rs3.99 Billion
≈ $43.13 Million
+10.14%
2024-03-31 Rs3.62 Billion
≈ $39.16 Million
+111.57%
2023-03-31 Rs1.71 Billion
≈ $18.51 Million
-17.49%
2022-03-31 Rs2.07 Billion
≈ $22.43 Million
-44.34%
2021-03-31 Rs3.73 Billion
≈ $40.30 Million
-54.94%
2020-03-31 Rs8.27 Billion
≈ $89.43 Million
+34.70%
2019-03-31 Rs6.14 Billion
≈ $66.39 Million
+93.54%
2018-03-31 Rs3.17 Billion
≈ $34.30 Million
+217.46%
2017-03-31 Rs999.19 Million
≈ $10.81 Million
--

About Krsnaa Diagnostics Limited

NSE:KRSNAA India Diagnostics & Research
Market Cap
$176.72 Million
Rs16.34 Billion INR
Market Cap Rank
#16825 Global
#863 in India
Share Price
Rs503.75
Change (1 day)
+1.16%
52-Week Range
Rs495.25 - Rs826.80
All Time High
Rs1020.15
About

Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, su… Read more